EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Is There Still a Role for Autologous Stem Cell Transplantation in the CAR T-Cell Era?

Tim Strüßmann, Reinhard Marks, Ralph Wäsch iD

Cancers · 23.05.2024 · 16 (11) · 1987

DOI: 10.3390/cancers16111987 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 23.05.2024. Verfasst von Tim Strüßmann und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine I, Faculty of Medicine, Medical Center-University of Freiburg, University of Freiburg, 79106 Freiburg, Germany. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recently, CD19-directed chimeric antigen receptor (CAR) T-cell therapies have revolutionized treatment strategies for diffuse large B-cell lymphoma (DLBCL). CAR T-cell therapy is increasingly used as a second-line therapy for patients with DLBCL with early relapse or refractoriness to initial chemoimmunotherapy and displaced high-dose chemotherapy, followed by autologous stem cell transplantation (ASCT) as the standard of care for these patients. However, patients with late relapse or chemosensitive disease still benefit from autologous stem cell transplantation. We will review practice-changing studies in early relapse (ZUMA-7 and TRANSFORM) under consideration of the negative BELINDA trial, with a focus on register data, comparing CAR T-cell therapy and ASCT for patients responding to salvage therapy.

Schlagwörter

Stichwörter der Autor:innen

CAR T-cell therapyDLBCLautologous stem cell transplantation

Autor:innen und Institutionen

  • Department of Medicine I, Faculty of Medicine, Medical Center-University of Freiburg, University of Freiburg, 79106 Freiburg, Germany.

ORCID-Profile: Ralph Wäsch

Zitieren

APA

Strüßmann, T., Marks, R., & Wäsch, R. (2024). Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Is There Still a Role for Autologous Stem Cell Transplantation in the CAR T-Cell Era?. Cancers, 16(11), 1987. https://doi.org/10.3390/cancers16111987

Vancouver

Strüßmann T, Marks R, Wäsch R. Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Is There Still a Role for Autologous Stem Cell Transplantation in the CAR T-Cell Era?. Cancers. 2024;16(11):1987. doi:10.3390/cancers16111987

BibTeX
@article{Strmann2024,
  author = {Strüßmann, Tim and Marks, Reinhard and Wäsch, Ralph},
  title = {Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Is There Still a Role for Autologous Stem Cell Transplantation in the CAR T-Cell Era?},
  journal = {Cancers},
  year = {2024},
  volume = {16},
  number = {11},
  pages = {1987},
  doi = {10.3390/cancers16111987}
}
Kostenlos starten →